Snowball logo
logo
1752

Nang Kuang Pharmaceutical Co Ltd

1752 โ€ข TW
NT$31.20-NT$0.15ย  (0.48%)
Estimate
P/E
15.4
EPS
2.02
Beta
0.135
Growth
Revenue, YoY
-0.58%
Net income, YoY
-0.37%
FCF, YoY
192.32%
Dividends
Dividend yield
5.13%
Annual payout
NT$1.60
Next ex. div date
July 2, 27
Payout
39.65%
Div.rating
About the company
Ticker
1752
ISIN
TW0001752004
Country
Taiwan
Sector (GICS)
Healthcare
Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in alimentary and metabolism, blood, antineoplastic and immunomodulatory, dermatological, genito-urinary and sex hormone, systemic hormone and antibacterial, cosmetics, and hospital solutions. In addition, the company is involved in trading of pharmaceuticals. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.

Frequently asked questions

What sector does Nang Kuang Pharmaceutical Co Ltd (1752) operate in?

Nang Kuang Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is Nang Kuang Pharmaceutical Co Ltd (1752) current stock price?

As of the latest data, Nang Kuang Pharmaceutical Co Ltd stock price is NT$31.20, with a previous close of NT$31.35. Nang Kuang Pharmaceutical Co Ltd lost -NT$0.15 in the last trading session, representing a -0.48% loss.

What is Nang Kuang Pharmaceutical Co Ltd (1752) current market capitalization?

Nang Kuang Pharmaceutical Co Ltd market cap is approximately 3.15 billion.

What is Nang Kuang Pharmaceutical Co Ltd (1752) Earnings Per Share (EPS)?

The trailing EPS is NT$2.02.

What is Nang Kuang Pharmaceutical Co Ltd (1752) Price-to-Earnings (P/E) ratio?

Nang Kuang Pharmaceutical Co Ltd current P/E ratio is 15.45.

What is Nang Kuang Pharmaceutical Co Ltd (1752) EBITDA?

Nang Kuang Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 121.53 million.

Does Nang Kuang Pharmaceutical Co Ltd (1752) pay dividends?

Yes. Nang Kuang Pharmaceutical Co Ltd pays annual dividends with an annualized yield of 5.13% and an estimated annual payout of NT$1.60 per share.

When is the next ex-dividend date for Nang Kuang Pharmaceutical Co Ltd (1752)?

The next ex-dividend date is scheduled for July 02, 2027.

What is Nang Kuang Pharmaceutical Co Ltd (1752) beta (volatility) score?

Nang Kuang Pharmaceutical Co Ltd has a beta of 0.135, indicating lower volatility than the overall market.